Center-Authored Papers

Filters: Keyword is Mice, Nude  [Clear All Filters]
A
Arnold RS, Sun CQ, Richards JC, Grigoriev G, Coleman IM, Nelson PS, Hsieh C-L, Lee JK, Xu Z, Rogatko A et al..  2009.  Mitochondrial DNA mutation stimulates prostate cancer growth in bone stromal environment.. The Prostate. 69(1):1-11. Abstract
C
Cao D, Sun Y, Wang L, He Q, Zheng J, Deng F, Deng S, Chang SC, Yu XP, Li M et al..  2015.  Alpha-momorcharin (α-MMC) exerts effective anti-human breast tumor activities but has a narrow therapeutic window in vivo.. Fitoterapia. 100:139-49. Abstract
D
Dahle J, Borrebaek J, Jonasdottir TJ, Hjelmerud AK, Melhus KB, Bruland ØS, Press OW, Larsen RH.  2007.  Targeted cancer therapy with a novel low-dose rate alpha-emitting radioimmunoconjugate.. Blood. 110(6):2049-56. Abstract
F
Fuchita M, Ardiani A, Zhao L, Serve K, Stoddard BL, Black ME.  2009.  Bacterial cytosine deaminase mutants created by molecular engineering show improved 5-fluorocytosine-mediated cell killing in vitro and in vivo.. Cancer research. 69(11):4791-9. Abstract
G
Girard E, Ditzler S, Lee D, Richards A, Yagle K, Park J, Eslamy H, Bobilev D, Vrignaud P, Olson J.  2015.  Efficacy of cabazitaxel in mouse models of pediatric brain tumors.. Neuro-oncology. 17(1):107-15. Abstract
Gopal AK, Pagel JM, Hedin N, Press OW.  2004.  Fenretinide enhances rituximab-induced cytotoxicity against B-cell lymphoma xenografts through a caspase-dependent mechanism.. Blood. 103(9):3516-20. Abstract
Gopal AK, Press OW, Wilbur SM, Maloney DG, Pagel JM.  2008.  Rituximab blocks binding of radiolabeled anti-CD20 antibodies (Ab) but not radiolabeled anti-CD45 Ab.. Blood. 112(3):830-5. Abstract
H
Halbert CL, Standaert TA, Wilson CB, Miller AD.  1998.  Successful readministration of adeno-associated virus vectors to the mouse lung requires transient immunosuppression during the initial exposure.. Journal of virology. 72(12):9795-805. Abstract
Hamblett KJ, Press OW, Meyer DL, Hamlin DK, Axworthy D, Wilbur SD, Stayton PS.  2005.  Role of biotin-binding affinity in streptavidin-based pretargeted radioimmunotherapy of lymphoma.. Bioconjugate chemistry. 16(1):131-8. Abstract
Hatton BA, Villavicencio EH, Tsuchiya KD, Pritchard JI, Ditzler S, Pullar B, Hansen S, Knoblaugh SE, Lee D, Eberhart CG et al..  2008.  The Smo/Smo model: hedgehog-induced medulloblastoma with 90% incidence and leptomeningeal spread.. Cancer research. 68(6):1768-76. Abstract
He H, Xu J, Nelson PS, Marshall FF, Chung LWK, Zhau HE, He D, Wang R.  2010.  Differential expression of the alpha2 chain of the interleukin-13 receptor in metastatic human prostate cancer ARCaPM cells.. The Prostate. 70(9):993-1001. Abstract
K
Koreckij TD, Trauger RJ, Montgomery RB, Pitts TEM, Coleman I, Nguyen H, Reading CL, Nelson PS, Vessella RL, Corey E.  2009.  HE3235 inhibits growth of castration-resistant prostate cancer.. Neoplasia (New York, N.Y.). 11(11):1216-25. Abstract
L
Laszlo GS, Cooper JA.  2009.  Restriction of Src activity by Cullin-5.. Current biology : CB. 19(2):157-62. Abstract
M
Mikheev AM, Mikheeva SA, Maxwell J-P, Rivo JV, Rostomily R, Swisshelm K, Zarbl H.  2008.  Dickkopf-1 mediated tumor suppression in human breast carcinoma cells.. Breast cancer research and treatment. 112(2):263-73. Abstract
P
Pagel JM, Laugen C, Bonham L, Hackman RC, Hockenbery DM, Bhatt R, Hollenback D, Carew H, Singer JW, Press OW.  2005.  Induction of apoptosis using inhibitors of lysophosphatidic acid acyltransferase-beta and anti-CD20 monoclonal antibodies for treatment of human non-Hodgkin's lymphomas.. Clinical cancer research : an official journal of the American Association for Cancer Research. 11(13):4857-66. Abstract
Pagel JM, Orgun N, Hamlin DK, Wilbur SD, Gooley TA, Gopal AK, Park SI, Green DJ, Lin Y, Press OW.  2009.  A comparative analysis of conventional and pretargeted radioimmunotherapy of B-cell lymphomas by targeting CD20, CD22, and HLA-DR singly and in combinations.. Blood. 113(20):4903-13. Abstract
Pagel JM, Pantelias A, Hedin N, Wilbur S, Saganic L, Lin Y, Axworthy D, Hamlin DK, Wilbur SD, Gopal AK et al..  2007.  Evaluation of CD20, CD22, and HLA-DR targeting for radioimmunotherapy of B-cell lymphomas.. Cancer research. 67(12):5921-8. Abstract
Pagel JM, Hedin N, Subbiah K, Meyer D, Mallet R, Axworthy D, Theodore LJ, Wilbur SD, Matthews DC, Press OW.  2003.  Comparison of anti-CD20 and anti-CD45 antibodies for conventional and pretargeted radioimmunotherapy of B-cell lymphomas.. Blood. 101(6):2340-8. Abstract
Palmer TD, Thompson AR, Miller AD.  1989.  Production of human factor IX in animals by genetically modified skin fibroblasts: potential therapy for hemophilia B.. Blood. 73(2):438-45. Abstract
Press OW, Corcoran M, Subbiah K, Hamlin DK, Wilbur DS, Johnson T, Theodore L, Yau E, Mallett R, Meyer DL et al..  2001.  A comparative evaluation of conventional and pretargeted radioimmunotherapy of CD20-expressing lymphoma xenografts.. Blood. 98(8):2535-43. Abstract
Press OW, Rosse C.  1977.  Thymic independence of the bone marrow lymphocyte phytohemagglutinin (PHA) response demonstrated in nude mice.. Cellular immunology. 28(1):218-28.
R
Rosse C, Press OW.  1978.  The differentiation of B and T lymphocytes from precursor cells resident in the bone marrow.. Blood cells. 4(1-2):65-85.
S
Sharma A, Yeow W-S, Ertel A, Coleman I, Clegg N, Thangavel C, Morrissey C, Zhang X, Comstock CES, Witkiewicz AK et al..  2010.  The retinoblastoma tumor suppressor controls androgen signaling and human prostate cancer progression.. The Journal of clinical investigation. 120(12):4478-92. Abstract
Sprenger CCT, Drivdahl RH, Woodke LB, Eyman D, Reed MJ, Carter WG, Plymate SR.  2008.  Senescence-induced alterations of laminin chain expression modulate tumorigenicity of prostate cancer cells.. Neoplasia (New York, N.Y.). 10(12):1350-61. Abstract
Stolworthy TS, Korkegian AM, Willmon CL, Ardiani A, Cundiff J, Stoddard BL, Black ME.  2008.  Yeast cytosine deaminase mutants with increased thermostability impart sensitivity to 5-fluorocytosine.. Journal of molecular biology. 377(3):854-69. Abstract